{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-285106","form_type":"8-K","ticker":"OSUR","cik":"0001116463","company_name":"ORASURE TECHNOLOGIES INC","filed_at":"2024-12-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.709646+00:00","generated_at":"2026-05-28T23:12:38.021718+00:00","sec_items":["1.01","2.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"OraSure acquires Sherlock Biosciences for $5M upfront plus up to $20M milestones and royalties on CT/NG test","bullets":["Upfront cash payment of $5M plus legal/insurance costs; merger closed December 19, 2024.","Two milestone payments up to $20M aggregate tied to regulatory approval of Sherlock's CT/NG test.","Quarterly mid-single-digit royalties on CT/NG test net sales through 2034.","Sherlock becomes wholly owned subsidiary; convertible notes, preferred, and common stock receive allocated consideration.","Stock options terminated without payment; financial statements to be filed by amendment within 71 days."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-285106","json":"https://secwatch.observer/filing/0001193125-24-285106.json","markdown":"https://secwatch.observer/filing/0001193125-24-285106.md","text":"https://secwatch.observer/filing/0001193125-24-285106.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1116463/000119312524285106/0001193125-24-285106-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1116463/000119312524285106/d884076d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T23:12:38.021718+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}